We are live on ! Find out more
WS

Wedbush Securities Portfolio holdings

AUM $3.43B
1-Year Est. Return 24.13%
This Fund
S&P 500
This Quarter Est. Return
+23.34%
1 Year Est. Return
+24.13%
3 Year Est. Return
+79.76%
5 Year Est. Return
+94.69%
10 Year Est. Return
+325.94%
AUM
$1.06B
AUM Growth
+$217M
Cap. Flow
+$46.1M
Cap. Flow %
4.35%
Top 10 Hldgs %
19.28%
Holding
1,042
New
162
Increased
350
Reduced
349
Closed
87

Top Buys

Rank Stock Value
1
ESGV icon
Vanguard ESG US Stock ETF
ESGV
+$6.69M
2
FTSM icon
First Trust Enhanced Short Maturity ETF
FTSM
+$5.29M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$4.28M
4
PTNQ icon
Pacer Trendpilot 100 ETF
PTNQ
+$3.37M
5
AIVC
Amplify Bloomberg AI Equal Weight ETF
AIVC
+$2.96M

Top Sells

Rank Stock Value
1
VTI icon
Vanguard Total Stock Market ETF
VTI
+$4.65M
2
SHV icon
iShares 0-1 Year Treasury Bond ETF
SHV
+$3M
3
UUP icon
Invesco DB US Dollar Index Bullish Fund
UUP
+$2.18M
4
PTLC icon
Pacer Trendpilot US Large Cap ETF
PTLC
+$1.36M
5
RTN
Raytheon Company
RTN
+$1.08M

Sector Composition

Rank Sector Weight
1 Technology 17.42%
2 Healthcare 10.07%
3 Consumer Discretionary 9.06%
4 Financials 7.61%
5 Communication Services 6.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WPG
926
DELISTED
Washington Prime Group Inc.
WPG
$24K ﹤0.01%
3,127
-100
-3% -$735
MNKD icon
927
MannKind Corp
MNKD
$1.28B
$22K ﹤0.01%
+12,400
New +$17.3K
CPE
928
DELISTED
Callon Petroleum Company
CPE
$21K ﹤0.01%
1,825
+175
+11% +$1.55K
ABUS icon
929
Arbutus Biopharma
ABUS
$865M
$20K ﹤0.01%
11,000
-32,000
-74% -$52.4K
PDSB icon
930
PDS Biotechnology
PDSB
$38.1M
$20K ﹤0.01%
+10,000
New +$11.1K
ACOR
931
DELISTED
Acorda Therapeutics
ACOR
$18K ﹤0.01%
208
-10
-5% -$1.06K
ASRT
932
DELISTED
Assertio
ASRT
$17K ﹤0.01%
333
+83
+33% +$4.28K
CSCI
933
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$16K ﹤0.01%
+200
New +$18.3K
CTIC
934
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$15K ﹤0.01%
12,600
– –
RGLS
935
DELISTED
Regulus Therapeutics
RGLS
$14K ﹤0.01%
2,058
-16
-0.8% -$105
AIG.WS
936
DELISTED
American International Group, Inc.
AIG.WS
$14K ﹤0.01%
10,095
– –
NBRV
937
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$14K ﹤0.01%
84
– –
VRDN icon
938
Viridian Therapeutics
VRDN
$2.13B
$11K ﹤0.01%
+667
New +$7.57K
MUX icon
939
McEwen Inc
MUX
$1.03B
$10K ﹤0.01%
1,020
-2,520
-71% -$23.4K
PLM
940
DELISTED
PolyMet Mining Corp.
PLM
$5K ﹤0.01%
1,150
– –
SDRL
941
DELISTED
Seadrill Limited Common Stock
SDRL
$4K ﹤0.01%
10,018
-2
-0% -$1
AAL icon
942
American Airlines Group
AAL
$9.58B
– –
-16,576
Closed -$202K
ACRS icon
943
Aclaris Therapeutics
ACRS
$730M
– –
-14,000
Closed -$15K
ALLE icon
944
Allegion
ALLE
$13B
– –
-5,085
Closed -$468K
APA icon
945
APA Corp
APA
$12.8B
– –
-10,113
Closed -$42K
APLT
946
DELISTED
Applied Therapeutics
APLT
– –
-10,000
Closed -$327K
BGC icon
947
BGC Group
BGC
$5.58B
– –
-22,148
Closed -$56K
BGY icon
948
BlackRock Enhanced International Dividend Trust
BGY
$512M
– –
-10,800
Closed -$49K
BKR icon
949
Baker Hughes
BKR
$56.8B
– –
-14,850
Closed -$156K
CCL icon
950
Carnival Corporation Ltd
CCL
$36.1B
– –
-13,249
Closed -$174K
36 37
38
39 40

Similar funds

CCM
Check Capital Management Costa Mesa, California $3.44B AUM 9.15% 1-Year Est. Return
SI
Sprott Inc Toronto, Ontario, Canada $3.44B AUM 125.26% 1-Year Est. Return
CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PWP
Perfromance Wealth Partners Hinsdale, Illinois $3.45B AUM 29.14% 1-Year Est. Return
RBA
Richard Bernstein Advisors New York $3.45B AUM 16.24% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
LNC
Lincoln National Corp Radnor, Pennsylvania $3.45B AUM 12.55% 1-Year Est. Return

Wedbush Securities's Q2 2020 Portfolio in Review

As of Q2 2020, Wedbush Securities held 1,042 positions worth $1.06B, up 26% from $840M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Wedbush Securities deployed $46.1M of net new capital in Q2 2020, opening 162 new positions and adding to 350 existing holdings. Its largest new stake was Vanguard ESG US Stock ETF: 127,200 shares worth $7.17M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Total Stock Market ETF, an estimated $4.65M trimmed.

  • Wedbush Securities's largest Q2 2020 buy was Vanguard ESG US Stock ETF: 127,200 shares worth $7.17M.
  • Wedbush Securities added most to First Trust Enhanced Short Maturity ETF in Q2 2020, an estimated $5.29M increase.
  • Wedbush Securities's biggest Q2 2020 reduction was Vanguard Total Stock Market ETF, cutting an estimated $4.65M.
  • Wedbush Securities fully exited Pacer Trendpilot US Large Cap ETF in Q2 2020, selling an estimated $1.36M.
  • Wedbush Securities's ten largest holdings make up 19% of its $1.06B portfolio in Q2 2020.
  • Wedbush Securities opened 162 new positions and closed 87 in Q2 2020.
  • Wedbush Securities's portfolio value rose 26% quarter-over-quarter to $1.06B.

Based on Wedbush Securities's 13F filing for Q2 2020, filed 16 Jul 2020.